GSE234767 GSE234769 dopamine 0 v 4 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE234767_GSE234769_dopamine_0_v_4_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE234767_GSE234769_dopamine_0_v_4_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE234767_GSE234769_dopamine_0_v_4_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE234767_GSE234769_dopamine_0_v_4_human_up.

Results found

Linked to

 

Label

Description

 

Gene

RNA, 7SL, cytoplasmic 525, pseudogene

Gene

long intergenic non-protein coding RNA 2026

Gene

ETV5 antisense RNA 1

Gene

MT-ND6 pseudogene 22

Gene

uncharacterized LOC105373953

Gene

ribosomal protein S7 pseudogene 6

Gene

uncharacterized LOC124904358

Gene

SUMO2 pseudogene 13

Gene

small nuclear ribonucleoprotein polypeptide G pseudogene 18

Gene

uncharacterized LOC102723896

  • Gene

    RNA, 7SL, cytoplasmic 525, pseudogene


  • Gene

    long intergenic non-protein coding RNA 2026


  • Gene

    ETV5 antisense RNA 1


  • Gene

    MT-ND6 pseudogene 22


  • Gene

    uncharacterized LOC105373953


  • Gene

    ribosomal protein S7 pseudogene 6


  • Gene

    uncharacterized LOC124904358


  • Gene

    SUMO2 pseudogene 13


  • Gene

    small nuclear ribonucleoprotein polypeptide G pseudogene 18


  • Gene

    uncharacterized LOC102723896

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.